Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.
作者信息
Magarò M, Zoli A, Altomonte L, Mirone L, Corvino G, Storti S, Marra R, Ricerca B M, Pagano L, Di Cesare L
出版信息
Ann Rheum Dis. 1990 Apr;49(4):268-9. doi: 10.1136/ard.49.4.268-b.
Abstract
摘要
相似文献
1
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.类风湿关节炎中的铁螯合作用：临床与实验室评估
Ann Rheum Dis. 1990 Apr;49(4):268-9. doi: 10.1136/ard.49.4.268-b.
2
Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine.类风湿关节炎中铁储存增加与贫血：去铁胺的作用
Br Med J (Clin Res Ed). 1984 Oct 13;289(6450):961-2. doi: 10.1136/bmj.289.6450.961.
3
High-dose intravenous chelation therapy with deferoxamine.去铁胺大剂量静脉螯合疗法。
Prog Clin Biol Res. 1989;309:125-31.
4
Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.去铁胺可降低类风湿关节炎患者体内的脂质过氧化物水平。
J Rheumatol. 1987 Aug;14(4):686-91.
5
Long term comparative studies in thalassemia patients treated with deferoxamine or a deferoxamine/deferiprone combination. Identification of effective chelation therapy protocols.对接受去铁胺或去铁胺/去铁酮联合治疗的地中海贫血患者进行长期比较研究。确定有效的螯合治疗方案。
Hemoglobin. 2008;32(1-2):41-7. doi: 10.1080/03630260701727085.
6
Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.β-地中海贫血患者螯合治疗相关并发症的临床监测与管理。
Expert Rev Hematol. 2016;9(2):151-68. doi: 10.1586/17474086.2016.1126176. Epub 2015 Dec 19.
7
Pharmacotherapy of iron overload in thalassaemic patients.地中海贫血患者铁过载的药物治疗
Expert Opin Pharmacother. 2003 Oct;4(10):1763-74. doi: 10.1517/14656566.4.10.1763.
8
Iron chelation with oral deferiprone in patients with thalassemia.
N Engl J Med. 1998 Dec 3;339(23):1712; author reply 1713-4.
9
[Iron chelation in 1998].
Transfus Clin Biol. 1998 Oct;5(5):353-6. doi: 10.1016/s1246-7820(98)85006-4.
10
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.重型地中海贫血联合螯合疗法治疗重度心肌铁沉着症伴左心室功能障碍。
J Cardiovasc Magn Reson. 2008 Feb 25;10(1):12. doi: 10.1186/1532-429X-10-12.
引用本文的文献
1
Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.细菌成分在类风湿性关节炎及其伴随的氧化应激、全身炎症和高凝状态中起主要作用。
Exp Biol Med (Maywood). 2017 Feb;242(4):355-373. doi: 10.1177/1535370216681549. Epub 2016 Nov 26.
2
Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice.通过改变小鼠铁稳态对TLR4激活的炎症反应进行选择性调节。
J Clin Invest. 2009 Nov;119(11):3322-8. doi: 10.1172/JCI39939. Epub 2009 Oct 5.
3
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.重组人促红细胞生成素对类风湿性关节炎合并慢性病贫血患者贫血及疾病活动的影响：一项随机、安慰剂对照、双盲、为期52周的临床试验
Ann Rheum Dis. 1996 Oct;55(10):739-44. doi: 10.1136/ard.55.10.739.
4
Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis.去铁胺疗法对类风湿关节炎相关慢性病贫血的影响。
Rheumatol Int. 1996;16(2):45-8. doi: 10.1007/BF01816434.
本文引用的文献
1
THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.去铁胺的生物化学及其与铁代谢的关系。
Ann N Y Acad Sci. 1964 Oct 7;119:758-68. doi: 10.1111/j.1749-6632.1965.tb54077.x.
2
Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients.类风湿关节炎中的脂质过氧化：类风湿患者滑液中的硫代巴比妥酸反应性物质及催化性铁盐
Clin Sci (Lond). 1984 Jun;66(6):691-5. doi: 10.1042/cs0660691.
3
The importance of iron in rheumatoid disease.铁在类风湿疾病中的重要性。
Lancet. 1981 Nov 21;2(8256):1142-4. doi: 10.1016/s0140-6736(81)90590-0.
4
Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.非血红素铁亚基特异性抑制剂对核糖核苷酸还原酶抑制作用的差异机制研究
Adv Enzyme Regul. 1984;22:231-41. doi: 10.1016/0065-2571(84)90016-5.
5
Concentration of iron in synovial membrane, synovial fluid, and serum in rheumatoid arthritis and other joint diseases.类风湿关节炎及其他关节疾病中滑膜、滑液和血清中铁的浓度。
Ann Rheum Dis. 1968 Jan;27(1):49-54. doi: 10.1136/ard.27.1.49.
6
Treatment of rheumatoid arthritis with desferrioxamine.用去铁胺治疗类风湿性关节炎。
Q J Med. 1986 Dec;61(236):1153-8.
7
Effect of iron chelation on inflammatory joint disease.铁螯合对炎性关节疾病的影响。
Ann Rheum Dis. 1987 Apr;46(4):327-33. doi: 10.1136/ard.46.4.327.
8
Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus.血清β2微球蛋白作为系统性红斑狼疮活动的标志物。
Scand J Rheumatol. 1986;15(2):201-5. doi: 10.3109/03009748609102089.
9
Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis.去铁胺的抗贫血及潜在抗炎活性：在类风湿关节炎中的可能用途
Clin Exp Rheumatol. 1986 Jan-Mar;4(1):25-9.
10
Deferoxamine induced decreases of lipid peroxides in rheumatoid arthritis.去铁胺可降低类风湿关节炎患者体内的脂质过氧化物水平。
J Rheumatol. 1987 Aug;14(4):686-91.
Zotero 插件